Navigation Links
Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
Date:9/10/2008

im to build on this by testing short treatments of several doses in future trials," said Steve Harris, Circassia's CEO. "Our goal for ToleroMune is to provide a range of allergy therapies that effectively and quickly treat the underlying disease while also offering excellent safety. Consequently, these positive clinical results will not only contribute to the development of our cat allergy product, but will also provide the foundations for our other allergy programmes that utilize our ToleroMune technology."

In addition to their potential clinical benefits, Circassia's anti-allergy products would have significant market opportunities. Currently, over 150 million people suffer from allergic rhinitis in the US and Europe and the market for current treatments, despite their limitations, is approximately $12 billion per year. The prevalence of cat-dander allergy is high, with 1-in-6 Americans and nearly 10% of Europeans suffering from the condition. Existing treatments have a number of issues, either providing symptomatic relief only or requiring lengthy supervision by specialist physicians. In contrast, Circassia's ToleroMune technology has the potential to rapidly desensitize sufferers using extremely small sections of allergens (termed T-cell epitopes), which minimizes the potential for adverse reactions.

About Circassia

Circassia is a specialty biopharmaceutical company focused on developing medicines designed to control immune system responses. The company has a highly experienced management team with a proven track record in product development and commercialization, and having successfully completed two fundraising rounds is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman Sachs and Invesco Perpetual.

Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization technology, ToleroMune. The company
'/>"/>

SOURCE Circassia Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
2. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
3. TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra, Levitra and Cialis Type Tablets
4. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
5. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
6. CureDMs Diabetes Therapy Achieves Major Development Milestone
7. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
8. Bionomics Achieves US$1 Million Milestone Payment from Genmab
9. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
10. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
11. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 Research and Markets ... "Will Theranos Turn the Lab Industry Upside Down?" ... received much praise along with a healthy dose of ... with their potentially disruptive laboratory solution. Behind all of ... Has Theranos scaled microfluidic technology across a comprehensive menu ...
(Date:5/4/2015)... (NASDAQ: LMNX ) today announced financial results for the ... include the following: , Consolidated first quarter revenue ... quarter of 2014. , First quarter assay revenue of ... of 2014. , Consolidated gross profit margin was 70 ... net income for the first quarter was $7.5 million or ...
(Date:5/4/2015)... , May 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: ... Aurora has joined the company as Vice President, ... to welcome Dr. Bill Aurora to the ... Kevin Gorman , President and Chief Executive Officer ... scientific exchange and outreach coupled with his extensive network ...
Breaking Medicine Technology:Will Theranos Turn the Lab Industry Upside Down? 2Luminex Corporation Reports First Quarter 2015 Results 2Luminex Corporation Reports First Quarter 2015 Results 3Luminex Corporation Reports First Quarter 2015 Results 4Luminex Corporation Reports First Quarter 2015 Results 5Luminex Corporation Reports First Quarter 2015 Results 6Luminex Corporation Reports First Quarter 2015 Results 7Luminex Corporation Reports First Quarter 2015 Results 8Luminex Corporation Reports First Quarter 2015 Results 9Luminex Corporation Reports First Quarter 2015 Results 10Luminex Corporation Reports First Quarter 2015 Results 11Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3
(Date:5/5/2015)... (PRWEB) May 05, 2015 May is National ... the Institute for Better Bone Health . Founded by ... aims to educate both consumers and physicians about the latest ... of bone health. , According to a study recently published ... total Americans are affected by osteoporosis and low bone mass. ...
(Date:5/5/2015)... HealthSlide, Inc ., a healthcare ... hospitals nationwide, has announced the launch of its ... CTOs can access the calculator on the company’s ... and ongoing savings of switching to the company’s ... pay an average of $300,000 a year on ...
(Date:5/5/2015)... Crawford Technologies announced today it has been awarded a ... of the Business Marketing Association (BMA) for the redesign of ... presented to the CrawfordTech marketing team on Friday, May 1, ... 300 people in attendance. , “The launch of the new ... shift in focus for how our company communicates our value ...
(Date:5/5/2015)... 05, 2015 B. E. Smith, the ... providers, has been retained to recruit a new ... The top executive search firm in the healthcare industry, ... healthcare executives into organizations. , Shodair Children’s Hospital is ... Montana to offer both acute and residential inpatient services, ...
(Date:5/5/2015)... Collingswood, NJ (PRWEB) May 05, 2015 ... document management, and end-to-end automation solutions, announced today that ... http://www.mcmutual.com/ and corporate identity. According to president and ... reboot are aligned with the company’s strategy for growth ... has been successful for the past 30 years by ...
Breaking Medicine News(10 mins):Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3Health News:HealthSlide Launches ROI Cost Calculator 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 2Health News:Crawford Technologies Awarded BMA’s ‘2015 Gold Key Award’ for Innovative Website Redesign 3Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 2Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 3Health News:McMunn Associates Launches New Corporate Branding with New Website 2
... ... Costly Manual Processes and Providing Greater Efficiency , ... Birmingham, AL (PRWEB) October 19, 2009 ... www.encirclehealth.com ) today announced the formation of a new partnership to offer an ...
... The International Osteoporosis Foundation (IOF) will issue a new ... on October 20, 2009. The report is available at ... Risk Assessment Tool, is a free online tool developed ... The tool helps clinicians to better identify women and ...
... ... and customer acquisition teams, recently volunteered for seven hours at the Habitat for Humanity ... the recent Columbus Fair in Columbus, Ohio. , ... Gahanna, OH (Vocus) October 18, 2009 -- Athens ...
... Year Against Musculoskeletal Pain launches today, focusing attention ... areas of pain. Sponsored by the nonprofit International ... 12-month campaign aims to generate greater awareness among ... general public about musculoskeletal pain and its substantial ...
... Oct. 18 American Dietetic Association,s Food & Nutrition ... and following the feeding guidance for infants, yet continued work ... eating habits for their growing children, suggests data from the ... a symposium at the American Dietetic Association,s Food & Nutrition ...
... Drugs made using unusual metals could form an effective treatment ... developed immunity to other drugs, according to research at the ... The study, published in the Journal of Medicinal Chemistry ... transition metals Ruthenium and Osmium, which are found in the ...
Cached Medicine News:Health News:SourceMedical Launches New Tool to Automate Insurance Eligibility Verification for Ambulatory Surgery Centers 2Health News:SourceMedical Launches New Tool to Automate Insurance Eligibility Verification for Ambulatory Surgery Centers 3Health News:New IOF report explains importance of FRAX in osteoporosis management 2Health News:Athens Consulting Volunteers Time To Habitat For Humanity 2Health News:IASP Sponsors Global Year Against Musculoskeletal Pain 2Health News:Study Shows That Diets of Infants are Improving; Concerns Remain for Toddlers and Preschoolers 2Health News:Study Shows That Diets of Infants are Improving; Concerns Remain for Toddlers and Preschoolers 3Health News:Study Shows That Diets of Infants are Improving; Concerns Remain for Toddlers and Preschoolers 4Health News:Study Shows That Diets of Infants are Improving; Concerns Remain for Toddlers and Preschoolers 5Health News:Study Shows That Diets of Infants are Improving; Concerns Remain for Toddlers and Preschoolers 6Health News:Study Shows That Diets of Infants are Improving; Concerns Remain for Toddlers and Preschoolers 7Health News:Metals could forge new cancer drug 2
... The Equalizer With 384 Well Plate Capability ... features of the original Equalizerexpandable and equal tip ... and in-lab calibration capabilities. In addition, this model ... to 4.5mm for loading and accessing many gels ...
... description: Quickly transfer samples from ... 64-lane gels. Accurately deliver 0.5-5 ... loaded in six minutes or ... and 377 and other gels ...
... Equally Spaced, Expandable, Multichannel Pipettor ... instantly boosts productivity with an industry breakthroughequal ... adjustment of a slide rod. This innovation ... liquids between vessels with different configurations. ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
Medicine Products: